Literature DB >> 25492617

Response to comments on 'competing designs for drug combination in phase I dose-finding clinical trials' by G. Yin, R. Lin and N. Wages.

Marie-Karelle Riviere1, Frédéric Dubois, Sarah Zohar.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25492617     DOI: 10.1002/sim.6332

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  1 in total

Review 1.  Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials.

Authors:  X Paoletti; M Ezzalfani; C Le Tourneau
Journal:  Ann Oncol       Date:  2015-06-18       Impact factor: 32.976

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.